The FDA has approved Quillivant XR (methylphenidate hydrochloride) from Next Wave Pharma for extended-release oral suspension for treatment of Attention...
The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed...
Pfizer has announced that the FDA has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets for the once-daily treatment...
Veloxis Pharmaceuticals A/S announced that Envarsus XR (extended release tacrolimus) was granted Orphan Drug status by the U.S. Food and...
On 5th November 2010 the FDA approved Kombiglyze XR from BMS/AstraZeneca, for the treatment of type 2 diabetes in adults....
The FDA has informed Veloxis of the tentative approval of Envarsus XR (tacrolimus extended relief) for Transplant Rejection. The FDA...
The FDA has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension,...
The FDA has accepted for review the supplemental new drug application (sNDA) for Trokendi XR (topiramate extended release), from Supernus...
The FDA has approved Adzenys XR-ODT (amphetamine extended release oral), from Neos Therapeutics, for the treatment of ADHD in patients...
Veloxis Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking a new indication for Envarsus XR...